Page 5 - IPA_1_2022
P. 5

Choose a dispersible


                         anti-inflammatory


                               from Aspen's


                           PANAMOR range.




















                                                                          diclofenac free

                                                                          acid 46,5 mg




            For short-term treatment of emergency acute gout attacks,
            subject to a maximum daily dose of 150 mg for a maximum

                                       treatment period of 3 days.
                             }            Dissolved quickly in water



           BENEFITS OF                    Improve patient compliance, particularly suitable for
           DISPERSIBLE                    elderly, bedridden and postoperative patients who have
           TABLETS :                      dif culty swallowing conventional tablets and capsules
                        1

                                          Well absorbed from the gastro-intestinal tract

                                   Keep Moving!





       1. Nandhini J, Rajalakshmi A.N. Dispersible Tablets: A Review. J Pharm Adv Res [Internet] 2018 April 30 [cited 2021 July 15]; 2018;1(3):148-155. Available from:
       http://www.jparonline.com/review/JPAR-1803-RVA-00028-Final-02.pdf
       S0 PANAMOR Gel (30 g). S1 PANAMOR Gel (60 g). S1 PANAMOR Gel (100 g). Reg. No.: 33/3.1/0058. Each 100 g gel contains 1,292 g diclofenac hydroxyethylpyrrolidine.
       S2 PANAMOR AT-50 ( lm-coated tablets). Reg. No.: R/3.1/50. Each  lm-coated tablet contains 50 mg diclofenac sodium. S2 PANAMOR 50 mg Dispersible Tablet. Reg.
       No.: A38/3.1/0383. Each PANAMOR 50 mg dispersible tablet contains 46,5 mg of diclofenac free acid. S3 PANAMOR Suppositories 12,5. Reg. No.: 27/3.1/0121. Each
       suppository contains 12,5 mg diclofenac sodium. S3 PANAMOR Suppositories 25. Reg. No.: Z/3.1/172. Each suppository contains 25 mg diclofenac sodium. S3 PANAMOR
       Suppositories 100. Reg. No.: Y/3.1/395. Each suppository contains 100 mg diclofenac sodium. S3 PANAMOR-75 SR Tablets. Reg. No.: 29/3.1/0121. Each  lm-coated tablet
       contains 75 mg diclofenac sodium. S3 PANAMOR-100 SR Tablets. Reg. No.: 29/3.1/0122. Each  lm-coated tablet contains 100 mg diclofenac sodium. For full prescribing
       information refer to the professional information approved by the medicines regulatory authority (PANAMOR Gel 03/2013. PANAMOR AT-50 09/1994. PANAMOR 50 mg
       Dispersible Tablet 02/2005. PANAMOR Suppositories 12,5 mg, PANAMOR Suppositories 25 mg, PANAMOR Suppositories 100 mg PANAMOR-75 SR, PANAMOR-100 SR
       09/1994). Trademarks are owned by or licensed to the Aspen Group of companies. © 2021 Aspen Group of companies or its licensor. All rights reserved. Pharmacare
       Limited. Co. Reg. No.: 1898/000252/06. Healthcare Park, Woodlands Drive, Woodmead, 2191. ZAR-A-LDI-08-21-00009 09/2021








                                                                                           Marketed by Aspen Pharmacare
                                                                                                 www.aspenpharma.com
                                                                                             Medical Hotline 0800 118 088
   1   2   3   4   5   6   7   8   9   10